PAM
ONC

Pinpoint Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Pinpoint Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,300
Closed -$2.79M – 135
2024
Q1 		$2.79M Buy
+5,300
New +$853K 0.45% 35
2023
Q4 		– Sell
-7,534
Closed -$3.61M – 89
2023
Q3 		$3.61M Buy
7,534
+3,436
+84% +$680K 0.85% 19
2023
Q2 		$1.61M Buy
+4,098
New +$944K 0.9% 12

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Pinpoint Asset Management's ONC Position: Q2 2024 in Review

Pinpoint Asset Management sold out of BeOne Medicines Ltd (ONC) in Q2 2024, closing a stake of 5,300 shares — an estimated $2.79M sold.

Pinpoint Asset Management first reported a position in ONC in Q2 2023 and held it in 3 quarters. The position peaked at $3.61M in Q3 2023. 200 funds tracked by Wall St. Rank hold ONC as of Q2 2024.

  • Pinpoint Asset Management reported no remaining BeOne Medicines Ltd position as of Q2 2024 after selling out during the quarter.
  • Pinpoint Asset Management sold 5,300 BeOne Medicines Ltd shares in Q2 2024, an estimated $2.79M.
  • Pinpoint Asset Management first reported a position in BeOne Medicines Ltd in Q2 2023 and held it in 3 quarters.
  • Pinpoint Asset Management's BeOne Medicines Ltd position peaked at $3.61M in Q3 2023.
  • 200 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2024.

Based on Pinpoint Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.